The prognostic effects of somatic mutations in ER-positive breast cancer

Authors

• Obi L. Griffith, Washington University School of Medicine in St. Louis
• Nicholas C. Spies, Washington University School of Medicine in St. Louis
• Malachi Griffith, Washington University School of Medicine in St. Louis
• Jingqin Luo, Washington University School of Medicine in St. Louis
• Jason Kunisaki, Washington University School of Medicine in St. Louis
• Christopher A. Miller, Washington University School of Medicine in St. Louis
• Kilannin Krysiak, Washington University School of Medicine in St. Louis
• Jasreet Hundal, Washington University School of Medicine in St. Louis
• Benjamin J. Ainscough, Washington University School of Medicine in St. Louis
• Zachary L. Skidmore, Washington University School of Medicine in St. Louis
• Katie Campbell, Washington University School of Medicine in St. Louis
• Catrina Fronick, Washington University School of Medicine in St. Louis
• Lisa Cook, Washington University School of Medicine in St. Louis
• Jacqueline E. Snider, Washington University School of Medicine in St. Louis
• Sherri Davies, Washington University School of Medicine in St. Louis
• Vincent Magrini, Washington University School of Medicine in St. Louis
• David E. Larson, Washington University School of Medicine in St. Louis
• Robert S. Fulton, Washington University School of Medicine in St. Louis
• Ron Bose, Washington University School of Medicine in St. Louis
• Richard K. Wilson, Washington University School of Medicine in St. Louis
• Elaine R. Mardis, Washington University School of Medicine in St. Louis
• et al

Journal

Nature Communications

Publication Date

2018

Volume

9

Issue

1

Inclusive Pages

3476

Document Type

Open Access Publication

DOI

10.1038/s41467-018-05914-x

Rights and Permissions

Griffith, O. L., Spies, N. C., Anurag, M., Griffith, M., Luo, J., Tu, D., . . . Ellis, M. J. (2018). The prognostic effects of somatic mutations in ER-positive breast cancer. Nature Communications, 9(1) doi:10.1038/s41467-018-05914-x. https://www.nature.com/articles/s41467-018-05914-x. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Recommended Citation

Griffith, Obi L.; Spies, Nicholas C.; Griffith, Malachi; Luo, Jingqin; Kunisaki, Jason; Miller, Christopher A.; Krysiak, Kilannin; Hundal, Jasreet; Ainscough, Benjamin J.; Skidmore, Zachary L.; Campbell, Katie; Fronick, Catrina; Cook, Lisa; Snider, Jacqueline E.; Davies, Sherri; Magrini, Vincent; Larson, David E.; Fulton, Robert S.; Bose, Ron; Wilson, Richard K.; Mardis, Elaine R.; and et al, "The prognostic effects of somatic mutations in ER-positive breast cancer." Nature Communications. 9, 1. 3476. (2018).
https://digitalcommons.wustl.edu/open_access_pubs/7082